Eyenovia Inc (EYEN)
1.01
+0.07
(+7.74%)
USD |
NASDAQ |
May 03, 16:00
1.02
+0.01
(+0.99%)
After-Hours: 20:00
Eyenovia Enterprise Value: 47.30M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 47.30M |
| May 02, 2024 | 43.86M |
| May 01, 2024 | 42.80M |
| April 30, 2024 | 35.02M |
| April 29, 2024 | 33.19M |
| April 26, 2024 | 29.21M |
| April 25, 2024 | 33.14M |
| April 24, 2024 | 27.09M |
| April 23, 2024 | 25.15M |
| April 22, 2024 | 23.91M |
| April 19, 2024 | 26.48M |
| April 18, 2024 | 24.60M |
| April 17, 2024 | 24.99M |
| April 16, 2024 | 25.66M |
| April 15, 2024 | 25.49M |
| April 12, 2024 | 24.55M |
| April 11, 2024 | 27.49M |
| April 10, 2024 | 25.19M |
| April 09, 2024 | 28.58M |
| April 08, 2024 | 34.02M |
| April 05, 2024 | 41.61M |
| April 04, 2024 | 41.77M |
| April 03, 2024 | 42.10M |
| April 02, 2024 | 45.13M |
| April 01, 2024 | 46.04M |
| Date | Value |
|---|---|
| March 28, 2024 | 46.16M |
| March 27, 2024 | 46.18M |
| March 26, 2024 | 47.30M |
| March 25, 2024 | 55.35M |
| March 22, 2024 | 53.46M |
| March 21, 2024 | 55.35M |
| March 20, 2024 | 57.25M |
| March 19, 2024 | 55.12M |
| March 18, 2024 | 71.94M |
| March 15, 2024 | 74.78M |
| March 14, 2024 | 72.78M |
| March 13, 2024 | 76.88M |
| March 12, 2024 | 74.60M |
| March 11, 2024 | 71.41M |
| March 08, 2024 | 71.41M |
| March 07, 2024 | 77.79M |
| March 06, 2024 | 76.65M |
| March 05, 2024 | 79.61M |
| March 04, 2024 | 103.30M |
| March 01, 2024 | 107.40M |
| February 29, 2024 | 98.06M |
| February 28, 2024 | 104.21M |
| February 27, 2024 | 97.83M |
| February 26, 2024 | 89.63M |
| February 23, 2024 | 76.42M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.12M
Minimum
Mar 18 2020
209.38M
Maximum
May 03 2023
73.99M
Average
67.28M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.813M |
| Alpine Immune Sciences Inc | 3.908B |
| Lantern Pharma Inc | 24.76M |
| Oragenics Inc | 3.216M |
| MAIA Biotechnology Inc | 60.36M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.967M |
| Revenue (Quarterly) | 0.0026M |
| Total Expenses (Quarterly) | 7.469M |
| EPS Diluted (Quarterly) | -0.16 |
| Profit Margin (Quarterly) | -307.7K% |
| Earnings Yield | -64.36% |
| Normalized Earnings Yield | -64.36 |